Knight Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Abir Therapeutics
  • Grupo Biotoscana
  • NeurAxon
  • Orphan Canada
  • Paladin Therapeutics.
See more in Biomedtracker

Latest on Knight Therapeutics, Inc.

Scrip

TherapeuticsMD Finds New Exit With Mayne Pharma Licensing Pact

 
• By Joseph Haas

Despite missing out on a proposed acquisition priced at about four times its share price at the time of offer, TherapeuticsMD Inc. has found an exit for its shareholders by selling off its women’s h

Scrip

Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership

Scrip

RedHill Biopharma Gets Rights To Naloxegol, No Longer Core At AstraZeneca

 
• By John Davis

Who : AstraZeneca/RedHill Biopharma What : AstraZeneca has sublicensed global rights to Movantik, excluding Europe, Canada and Israel, to RedHill Biopharma. Why : Gastrointestinals are outside of As

Scrip

Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . AstraZeneca Calls On Cheplap